Quality of life outcomes following surgery for advanced ovarian cancer: a systematic review and meta-analysis.
Satyam KumarJoanna LongSean KehoeSudha SundarCarole CumminsPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2019)
There was no clinically important difference in the quality of life of patients undergoing either primary debulking surgery or neoadjuvant chemotherapy. There is insufficient evidence on quality of life outcomes of patients undergoing extensive or ultra-radical surgery compared with those undergoing less extensive surgery. Quality of life outcomes matter to patients, but there is little evidence to inform patient choice regarding the extent of surgery.
Keyphrases
- minimally invasive
- coronary artery bypass
- neoadjuvant chemotherapy
- patients undergoing
- surgical site infection
- locally advanced
- ejection fraction
- end stage renal disease
- high resolution
- newly diagnosed
- metabolic syndrome
- percutaneous coronary intervention
- early stage
- mass spectrometry
- adipose tissue
- sentinel lymph node
- skeletal muscle
- weight loss